Turn ₹10,000 Into ₹1 Lakh? Sattva Sukun’s ₹1 Rights Issue Could Be the Jackpot!

Sattva Sukun Lifecare Ltd

• KBC Global

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

NSElive

• bselive
• nselive

28 Mar, 2025 15:16

0.98

-0.03 (-2.97%)

Volume 2723927

Todays L/H 0.980.99

More

×

Strong Financial Turnaround with Explosive Profit Growth

The company reported PAT of Rs 2.48 crore for FY25, representing a 1300% YoY surge over FY24. Revenues doubled over two years, jumping from Rs 2.21 crore in FY23 to Rs 5.26 crore in FY25. With robust demand and efficient cost management, Sattva Sukun has transitioned from a microcap outlier to a company showing visible signs of scalable growth.

Zero Debt & Strong Margins

Sattva Sukun remains completely debt-free, a rare trait in its segment. Even more impressive, it reported operating margins exceeding 60%, signaling a capital-light, high-efficiency business model. This positions it favorably for both domestic and international scaling without financing risk.

Factory Expansion Adds Strategic Moat The company commissioned a new GI-certified manufacturing unit in Firozabad focused on premium home decor: aroma diffusers, chandeliers, decorative glassware, and spiritual accessories. The move is expected to bolster export capabilities and improve brand value in the lifestyle and gifting segment. Aggressive Capital Deployment from Rights Issue The Rs 48.96 crore rights issue is priced at just Rs 1/share, versus CMP of Rs 1.10–1.20. Importantly, this capital is not for debt repayment but growth: Rs 15 Cr investment in a diamond trading entity (strategic diversification) Rs 15 Cr into associate real estate arm Sai Karan Buildtech Rs 5 Cr for factory scaling Rs 4.7 Cr for working capital Such utilization highlights a proactive capital allocation strategy aligned with long-term value creation.

Young Promoter Driving Execution The company is led by a second-generation promoter under 30, known for his aggressive vision and quick execution. His leadership marks a break from legacy microcap inertia and is focused on speed, scale, and synergy across verticals. Investor Flexibility via RE Trading The rights issue remains open from 28 May to 26 June 2025, with RE (Rights Entitlement) trading available on BSE between 28 May and 20 June. Even investors who weren’t on record as of 9 May can participate by purchasing RE shares from the secondary market. There is no cap on how many shares one can apply for based on RE quantity. Why This May Be the Most Secure Penny Stock Bet of 2025 Entry price of Rs 1 offers downside cushion Clean balance sheet and high margins de-risk investment Multi-sector presence (decor, diamonds, real estate) adds diversification Rising revenues and profits signal strong execution Rights issue priced for retail accessibility

Highlights:- Final Take: Sattva Sukun Lifecare's fundamentals, strategic direction, and investor-friendly rights issue make it one of the few penny stocks that balances safety with multibagger potential. For investors seeking high-reward opportunities with limited downside, this might just be the opportunity to accumulate before broader market discovery. Target Price: Rs 5 (Medium Term).

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.